HIGHLIGHTS
- who: Zhenkang Qiu from the Department of Endoscopy, Sun Yat-sen University Center Medicine, Guangzhou, Guangdong, China have published the research work: TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension, in the Journal: (JOURNAL)
- future: A more significant number of cases and longer follow-up are necessary for survival analysis in future studies.
SUMMARY
Hepatocellular carcinoma (HCC) is one of the most common malignancies often connected to liver cirrhosis and portal hypertension. New treatment modalities, such as lenvatinib and immune checkpoint inhibitors, have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.